Inter-individual Physiological Response to a Training and Detraining Period in Cardiometabolic Risk Factors Subjects
VASCU-HEALTH
Physiological Response to a Training and Detraining Period in Vascular Parameters of Cardiometabolic Risk Factors Subjects: Optimizing Post-exercise Strategies to Maintain Health Benefits in Chilean Adults
1 other identifier
interventional
75
1 country
1
Brief Summary
Background: Although exercise training is a well described therapy for some cardiometabolic diseases such as obesity, type 2 diabetes, arterial hypertension, and metabolic syndrome, there is scarcity of knowledge about the post-exercise period term as 'detraining' where usually all physiological adaptations as cardiovascular and metabolic benefits are lost due to physical inactivity. Likewise, as some exercise training modalities as high-intensity interval training improve vascular parameters including endothelial dysfunction parameters as flow-mediated dilation (FMD%), and carotid-intima media thickness (c-IMT) during the 'training' period, there is little knowledge about how many 'volume' or 'intensity' of exercise training or physical activity per week is needed to maintain the exercise training benefits in populations with cardiometabolic risk factors such as those patients with arterial hypertension. This information will be of great interest for both improving and maintaining the vascular profile and health of Chilean adults with risk factors and to maintain a better vascular profile. Objective: To study the beneficial adaptations from the 'training' and 'detraining' period of exercise training on functional and structural vascular parameters in healthy and cardiometabolic risk factors adult subjects to improve the health profile. Methods: The investigators will conduct an experimental design of 5 groups of exercise training in healthy (controls) and hypertensive (HTN) patients (≥140 mmHg), with overweight/or obesity, men and women, with BMI ≥25 and ≤35 kg/m2, aged ≥18y, physically inactive (\<150 min/week of low/moderate PA/week, or \<75 min/week of vigorous PA) in the last 6 months will be invited for participating. The groups will be as follows; Group (HTNex will be compared with Group HTNcg). Group (ELEex will be compared with Group ELEcg). Group (NTex will be compared with Group NTcg). Each group will be compared in their physiological vascular adaptations before and after exercise training such as HIIT, and after 3 months of a detraining period. Results (hypothesis): The investigators hypothesized that the maintenance of vascular outcomes after the 'detraining' period is intensity-dependent in adults with HTN that participated of an exercise intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 28, 2022
CompletedFirst Submitted
Initial submission to the registry
January 20, 2023
CompletedFirst Posted
Study publicly available on registry
February 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2024
CompletedMay 29, 2024
May 1, 2024
1.9 years
January 20, 2023
May 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Flow-mediated dilation in (cm)
Change in flow-mediated dilation in the brachial artery registered by a linear transducer using images from a Doppler ultrasound
Baseline, 6 weeks, 12 weeks after exercise training intervention, and after 6 weeks, and 12 weeks follow-up
Pulse wave velocity in (m/s)
Change in pulse wave velocity in the brachial artery registered by an oscillometric cuff in the brachial artery
Baseline, 6 weeks, 12 weeks after exercise training intervention, and after 6 weeks, and 12 weeks follow-up
Carotid intima media thickness in (cm)
Change in Carotid intima media thickness in common carotid artery registered by a linear transducer using images from a Doppler ultrasound
Baseline, 6 weeks, 12 weeks after exercise training intervention, and after 6 weeks, and 12 weeks follow-up
Secondary Outcomes (31)
Body mass in (kg)
Baseline, 6 weeks, 12 weeks after exercise training intervention, and after 6 weeks, and 12 weeks follow-up
Height
Baseline, 6 weeks, 12 weeks after exercise training intervention, and after 6 weeks, and 12 weeks follow-up
Body mass index in (kg/m2)
Baseline, 6 weeks, 12 weeks after exercise training intervention, and after 6 weeks, and 12 weeks follow-up
Body fat in (%)
Baseline, 6 weeks, 12 weeks after exercise training intervention, and after 6 weeks, and 12 weeks follow-up
Skeletal muscle mass in (%)
Baseline, 6 weeks, 12 weeks after exercise training intervention, and after 6 weeks, and 12 weeks follow-up
- +26 more secondary outcomes
Study Arms (6)
HTNex
EXPERIMENTALThe participants will adhere to 12 weeks of exercise training, three times a week.
HTNcg
NO INTERVENTIONThese participants will maintain their normal lifestyle without intervention.
ELEex
EXPERIMENTALThe participants will adhere to 12 weeks of exercise training, three times a week.
ELEcg
NO INTERVENTIONThese participants will maintain their normal lifestyle without intervention.
NTex (Control Group-exercise)
EXPERIMENTALThe participants will adhere to 12 weeks of exercise training, three times a week.
NTcg (Control Group-no exercise)
NO INTERVENTIONThese participants will maintain their normal lifestyle without intervention.
Interventions
The intervention will consist in adhering to high-intensity interval training and/or resistance training three times a week
Eligibility Criteria
You may qualify if:
- Healthy, or subjects with elevated blood pressure (ELE) or arterial hypertension (HTN)
- ELE and/or HTN controlled or not controlled with pharmacotherapy
- With hyperglycemia, type 2 diabetes mellitus (T2DM) controlled or not controlled with pharmacotherapy
- Living in urban areas of the Concepción or Talcahuano cities
- Demonstrable ability to adhere to the exercise training programs
- To sign the written informed consent for participating in the study
You may not qualify if:
- Altered ECG
- Uncontrolled HTN (≥160 mmHg SBP, or DBP \>95 mmHg)
- Morbid obesity (≥35-40 kg/m2)
- Type 1 diabetes mellitus
- Cardiovascular disease (i.e., coronary artery disease)
- T2DM complications such as varicose ulcer in the foot, legs, or any history of the wound, nephropathies, muscle-skeletal disorders (i.e., osteoarthrosis) that could limit exercise participation, and adaptations, where ExT can be not recommended.
- Subjects under pharmacotherapy that can influence body composition such as weight- loss treatment, as well as those who are enrolled in ExT programs recently (last 3 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cristian Alvarezlead
Study Sites (1)
Universidad Andres Bello
Talcahuano, Chile
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Rodrigo Araneda, PhD
Universidad Andres Bello
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- According to availability and the feasibility of the enrolment's requirements, patients will be allocated to an arterial hypertension group (HTN), an elevated blood pressure (Ele), and a last normotensive (NT) experimental group, and thus randomly allocated to an experimental (HTNex, Eleex, NTex) or control group (HTNcg, Elecg, NTcg) in where subjetcs will not do HIIT exercise.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 20, 2023
First Posted
February 2, 2023
Study Start
June 28, 2022
Primary Completion
May 24, 2024
Study Completion
May 25, 2024
Last Updated
May 29, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share